Zynerba Pharmaceuticals
0
0
+€0,00+0% 00:00 Hari ini
Statistik
Tertinggi hari ini
-
Terendah hari ini
-
Tertinggi 52M
-
Terendah 52M
-
Volume
-
Vol. rata2
-
Kap. pasar
0
Rasio P/E
-
Imbal hasil dividen
-
Dividen
-
Pesaing
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Show more...
CEO
Mr. Armando Anido MBA
Karyawan
28
Negara
Amerika Serikat
ISIN
US98986X1090
Pencatatan
0 Comments
Bagikan pendapatmu
FAQ
Apa simbol saham Zynerba Pharmaceuticals?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa Boerse Stuttgart, saham Zynerba Pharmaceuticals diperdagangkan dengan simbol 6ZY.STU.
Berapa jumlah karyawan Zynerba Pharmaceuticals?▼
Per Juli 17, 2026, perusahaan memiliki 28 karyawan.
Zynerba Pharmaceuticals berada di sektor apa?▼
Zynerba Pharmaceuticals beroperasi di sektor Lainnya.
Kapan Zynerba Pharmaceuticals menyelesaikan split saham?▼
Zynerba Pharmaceuticals belum melakukan split saham baru-baru ini.
Di mana kantor pusat Zynerba Pharmaceuticals?▼
Kantor pusat Zynerba Pharmaceuticals berlokasi di Devon, Amerika Serikat.